SEC Form 4 · accession 0001654954-19-000453
Pharma-Bio Serv, Inc. · PBSV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dov Perlysky
Director
Period of report
Jan 10, 2019
Accepted (ET)
Jan 14, 2019 · 6:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001304161
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $1.00 | Jan 10, 2019 | A | 20,000 | A | — | Jan 10, 2024 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The option vests in two equal installments on July 10, 2019 and July 10, 2020.